| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/10/2004 | CN1141099C Antibacterial cephalosporin composition |
| 03/10/2004 | CN1141098C New application of benzene ring pelargonate hydrochloride |
| 03/10/2004 | CN1141097C Stabilized compositions containing benzimidzole-type compounds |
| 03/10/2004 | CN1141096C Use of 1-hydroxy-2-pyridones for treatment of skin diseases |
| 03/10/2004 | CN1141095C Preparation containing combination of N-5-methylisoxazole-4-carboxylic acid-(4-trifluoromethy1)-anilid and N-(4 trifluoromethylphenyl)-2-cyano-3-hyroxycrotonic acid amide |
| 03/10/2004 | CN1141094C Medicinal use of hypotensive and anti-tumour compound |
| 03/10/2004 | CN1141093C Anticancer lichee lectone medicine and its prepn |
| 03/10/2004 | CN1141092C Composition for preventing and treating osteoporosis and cancer and decreasing decreasing blood fat and its application |
| 03/10/2004 | CN1141091C Application of full-trans-tretinoin in preparing medicines to cure myocardial hypertrophy and vessel wall hyperplasia |
| 03/10/2004 | CN1141090C Slowly-releasing magnesium propylvalerate tablet and its preparing process |
| 03/10/2004 | CN1141089C Antimicrobials |
| 03/10/2004 | CN1141088C Novel therapeutic injectable analgesic composition containing nimesulide and process for manufacture thereof |
| 03/10/2004 | CN1141087C Release-controlling coating of antineoplastic lomustine for preventing tumour |
| 03/10/2004 | CN1141086C Hypoglycemic Chinese medicine 'yanzizhang' and its preparing process |
| 03/10/2004 | CN1141085C Water soluble clomiphene preparation and its preparation method |
| 03/10/2004 | CN1141084C Traditional Chinese medicine preparation for curing angiocardiopathy or cerebrovascular disease |
| 03/09/2004 | US6704749 Integrated hangtag production system |
| 03/09/2004 | US6703522 Alkyl amino acid derivatives useful as pharmaceutical agents |
| 03/09/2004 | US6703506 Amino acid ester containing azole antifungals |
| 03/09/2004 | US6703502 Spiroazo bicyclic heterocyclic |
| 03/09/2004 | US6703494 Thrombosis, adult respiratory system disorders |
| 03/09/2004 | US6703486 Peripheral nervous system specific sodium channels |
| 03/09/2004 | US6703444 Contacting with crosslinking agents so as to form two or more chemically distinct crosslinks between hyaluronic acid and the polymer; products with medical applications |
| 03/09/2004 | US6703427 Sodium lauryl ether sulfate is chosen as surfactant a, and one or more cosurfactants such as n-acylamino acids and salts, taurates, betanines etc. for reducing binding of surfactant a to the surface of the skin |
| 03/09/2004 | US6703425 Sulfonamide derivatives |
| 03/09/2004 | US6703424 Dispersible compositions containing L-DOPA ethyl ester |
| 03/09/2004 | US6703423 For therapy of polymorphoneutrophil (pmn) inflammation |
| 03/09/2004 | US6703422 For therapy and prophylaxis of cardiovascular disease, dyslipidemia; dyslipoproteinemia; disorder of glucose metabolism; alzheimer's disease; syndrome x; peroxisome proliferator activated receptor-associated disorder |
| 03/09/2004 | US6703421 Administering nf-kappa b inhibitor |
| 03/09/2004 | US6703418 Administering to a symptomatic hiv infected patient to improve an appetite and reduction in loss of weight, and effective amount of delta-9-tetrahydrocannabinol |
| 03/09/2004 | US6703417 Improved bioavailability; anticarcinogenic |
| 03/09/2004 | US6703414 A stent comprised of a stent body coated with a compound of the following formula:with hetero compounds |
| 03/09/2004 | US6703413 Production of apoptotic films for direct contact with tumors |
| 03/09/2004 | US6703412 Administered after human has attempted to go to sleep and has failed or has reawakened; side effect reduction |
| 03/09/2004 | US6703411 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 03/09/2004 | US6703410 Crystal forms of 3-(2,4-dichlorobenzyl)-2-methyl-n-(pentylsulfonyl)-3h-benzimidazole-5-carboxamide |
| 03/09/2004 | US6703406 Treatment of nervous system, psychological, and eating disorders; drug abuse, drug dependence |
| 03/09/2004 | US6703404 Nitric oxide synthase inhibitors |
| 03/09/2004 | US6703403 Method for improving pharmacokinetics |
| 03/09/2004 | US6703402 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof |
| 03/09/2004 | US6703400 Methods for treating multidrug resistance |
| 03/09/2004 | US6703399 Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
| 03/09/2004 | US6703398 Orally administered analgesic compositions containing nalbuphine |
| 03/09/2004 | US6703397 Pyrimidinyl methyl indole derivatives with antibacterial activity |
| 03/09/2004 | US6703396 Cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-oxathiolane-5-yl) -(1h)-pyrimidin-2-one |
| 03/09/2004 | US6703395 Administering2-(((3-hydroxypropyl)amino)-6-benzylamino)-9 -isopropylpurine or its salt for therapy of leukemia |
| 03/09/2004 | US6703393 Treatment of a variety of central nervous system (cns) disorders in humans, domesticated companion animals and livestock animals. treatment of anxiety, depression, a sleep disorder, attention deficit disorder, or alzheimer's dementia, |
| 03/09/2004 | US6703392 Orexin receptor antagonists for obesity or sleeping disorder treatment |
| 03/09/2004 | US6703391 Quinoxalinedione derivatives, their preparation and use |
| 03/09/2004 | US6703389 Optically pure reboxetine or its methanesulfonate salt inhibits reuptake of norepinephrine |
| 03/09/2004 | US6703387 Inhibitors of HPV E1 helicase enzyme |
| 03/09/2004 | US6703386 Treating hyperlipidemia, arteriosclerosis and hypercholesterolemia; derivatives of ezetimibe that are absorbed to a very low extent and so have a side effect reduction |
| 03/09/2004 | US6703382 Promoting apoptosis by administering compounds such as 2,9-dimethoxy-11,12-dihydrodibenzo(c,g)(1,2)diazocine-5,6-dioxide; anticancer agents |
| 03/09/2004 | US6703380 Prevention of cancer |
| 03/09/2004 | US6703378 Vitreoretinal tamponades based on fluorosilicone fluids |
| 03/09/2004 | US6703377 Viscosity; biodegradability; fibroblast growth factor |
| 03/09/2004 | US6703376 Administering to the airways of the patient a uridine phosphate such as uridine 5'triphosphate or di(uridine5') tetraphosphate for promoting drainage of mucous secretions in the congested airways of a bedridden/immobilized patient |
| 03/09/2004 | US6703372 Macrolides |
| 03/09/2004 | US6703371 Preparations for reducing oxygen consumption during physical efforts |
| 03/09/2004 | US6703370 Alleviating pain, fatigue, and irritable bowel syndrome; administering by mouth |
| 03/09/2004 | US6703369 Lipase inhibiting compositions |
| 03/09/2004 | US6703368 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
| 03/09/2004 | US6703359 Treating toxic hypervolemia, renal failure, congestive heart failure, nephrotic syndrome, pulmonary edema, and hypertension |
| 03/09/2004 | US6703215 Detecting preferential enzyme inhibitor; obtain substrate, incubate with enzyme mixture, expose to enzyme inhibitor, monitor for decrease in enzymatic activity |
| 03/09/2004 | US6703052 Long chain monounsaturated alcohol mixtures |
| 03/09/2004 | US6703050 Methods and compositions for the prevention or treatment of cancer |
| 03/09/2004 | US6703046 Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use |
| 03/09/2004 | US6703045 Composition and method for maintaining blood glucose level |
| 03/09/2004 | US6703044 Venlafaxine formulations |
| 03/09/2004 | US6703032 Pickering emulsions, comprising an oil phase, a water phase, one type of microfine particles which display both hydrophilic and lipophilic properties, dispersible both in water and in oil, a cyclodextrin and one or more emulsifiers |
| 03/09/2004 | US6703030 Comprising a carboxylated, acidic amino acid obtained by acidifying an acidic amino acid with a carboxylic acid and a carrier; nonirritating |
| 03/09/2004 | US6703022 Composition and method useful for treating colic |
| 03/09/2004 | US6703013 Controlled particle size; composition of gelling agent, thickener and water |
| 03/09/2004 | US6703008 Aerosol hair spray compositions comprising combinations of silicone-grafted copolymers |
| 03/09/2004 | US6702998 Methods and devices for treating lung dysfunction |
| 03/09/2004 | US6702997 Premeasured single unit dose; may be free of anti-microbial preservatives, such as benzalkonium chloride. |
| 03/09/2004 | US6702839 Method of controlling body temperature while reducing shivering |
| 03/09/2004 | US6702803 Multi-step drug dosage forms |
| 03/09/2004 | US6702733 Expanded clitoral sensitizing compounds with methods and apparatus for the delivery of these compounds |
| 03/09/2004 | US6702683 Metering and packaging of controlled release medication |
| 03/09/2004 | CA2408198C Pharmaceutical composition comprising cefuroxime axetil |
| 03/09/2004 | CA2323929C Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 03/09/2004 | CA2322188C The use of fumaric acid derivatives in transplant medicine |
| 03/09/2004 | CA2315796C Novel substances kf-1040 and process for producing the same |
| 03/09/2004 | CA2272463C Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| 03/09/2004 | CA2268868C Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery |
| 03/09/2004 | CA2260992C Eye treatments using synthetic thyroid hormone compositions |
| 03/09/2004 | CA2260016C Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 03/09/2004 | CA2097278C Hair-growing composition |
| 03/09/2004 | CA2086343C Sustained release thyroactive composition |
| 03/09/2004 | CA2052229C Antifungal composition in a dry powdered spray form |
| 03/05/2004 | CA2439440A1 Treatment of tuberous sclerosis associated neoplasms |
| 03/05/2004 | CA2437690A1 Ganoderma lucidum spores for treatment of autoimmune diseases |
| 03/04/2004 | WO2004019032A1 Bioequivalence test for iron-containing formulations |
| 03/04/2004 | WO2004018999A2 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 03/04/2004 | WO2004018686A1 Caged tetracycline (derivatives), their generation, and their use for photoactivated gene expression |
| 03/04/2004 | WO2004018678A1 Preventives/remedies for cancer |
| 03/04/2004 | WO2004018676A2 Rnai probes targeting cancer-related proteins |
| 03/04/2004 | WO2004018675A1 Treatment of melanoma by reduction in clusterin levels |
| 03/04/2004 | WO2004018669A1 Salt-inducible kinases 2 and use thereof |